Alberto Fernández-Tejada is Ikerbasque Research Professor and Group Leader of the Chemical Immunology Laboratory at CIC bioGUNE (Biscay, Spain). In 2009, he obtained his PhD in Chemistry from the University of La Rioja (Spain) with Prof. Corzana. From 2010 to 2014, he carried out postdoctoral research with Prof. Gin and Prof. Danishefsky at Memorial Sloan Kettering Cancer Center (USA) funded through a Fulbright and Marie Curie International Fellowship. After further postdoctoral studies with Prof. Jiménez-Barbero (CIB-CSIC, CIC bioGUNE, Spain) and Prof. Davis at the University of Oxford (UK), in 2017 he started his independent career in CIC bioGUNE funded through an ERC Starting Grant. His research program at the chemistry–immunology frontier is focused on the development of novel chemical tools to advance molecular adjuvants and synthetic glycopeptide vaccines as well as to probe protein O-GlcNAc glycosylation.